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Abstract
Aims—To investigate swept-source optical coherence tomography (OCT) angiography in the 
optic nerve head (ONH) and parafoveal regions in patients with multiple sclerosis (MS).
Methods—Fifty-two MS eyes and 21 healthy control (HC) eyes were included. There were two 
MS subgroups: 38 MS eyes without an optic neuritis (ON) history (MS −ON), and 14 MS eyes 
with an ON history (MS +ON). The OCT images were captured by high-speed 1050 nm swept-
source OCT. The ONH flow index (FI) and parafoveal FI were quantified from OCT angiograms.
Results—The mean ONH FI was 0.160±0.010 for the HC group, 0.156±0.017 for the MS−ON 
group, and 0.140±0.020 for the MS+ON group. The ONH FI of the MS+ON group was reduced 
by 12.5% compared to HC eyes (p=0.004). A higher percentage of MS+ON eyes had abnormal 
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ONH FI compared to HC patients (43% vs 5%, p=0.01). Mean parafoveal FIs were 0.126±0.007, 
0.127±0.010, and 0.129±0.005 for the HC, MS−ON, and MS +ON groups, respectively, and did 
not differ significantly among them. The coefficient of variation (CV) of intravisit repeatability 
and intervisit reproducibility were 1.03% and 4.53% for ONH FI, and 1.65% and 3.55% for 
parafoveal FI.
Conclusions—Based on OCT angiography, the FI measurement is feasible, highly repeatable 
and reproducible, and it is suitable for clinical measurement of ONH and parafoveal perfusion. 
The ONH FI may be useful in detecting damage from ON and quantifying its severity.
INTRODUCTION
Multiple sclerosis (MS), characterised by demyelination, axonal injury and gliosis, 
inflammation, and diffuse axonal degeneration throughout the central nervous system, is 
generally considered an inflammatory autoimmune disease.1 Optic neuritis (ON), a common 
feature of MS, may affect blood perfusion of the larger ocular vessels and possibly damage 
visual acuity.2 Vascular abnormalities, which may be caused by the abnormal function of 
cerebral endothelial cells, may play an important role in the formation of MS lesions and 
disease progression.3 Several studies have reported that vascular abnormalities, such as 
ischaemic stroke and global cerebral hypoperfusion, exist in patients with MS, and patients 
with MS with vascular risk factors have a more rapid disability progression than those who 
do not.45 However, characterisation of cerebral blood flow can be challenging. Studying the 
circulation of the optic nerve head (ONH) and parafoveal areas of the eye in MS patients 
may provide insight into the role of the more global vascular changes in the pathogenesis of 
MS.
Different methods have been used to detect the ocular blood perfusion in clinical practice 
and experimental research. Fluorescein angiography (FA) and indocyanine green 
angiography provide qualitative evaluation of retinal and choroidal circulation, but do not 
provide objective quantitative measurements.67 Although laser Doppler flowmetry (LDF) 
and laser speckle flowgraphy (LSFG) can measure retinal blood flow, the results are too 
variable to be used in clinical diagnosis.89 MRI ocular blood flow measurement has low 
spatial resolution and long acquisition time, is susceptible to movement artefacts, is limited 
by assumptions in the blood flow calculation, and has relatively high costs.10 Ultrasound 
colour Doppler imaging (CDI) can provide independent haemodynamic measurements of 
the retinal and uveal vascular beds, but due to limited resolution, it cannot provide precise 
measurements of retinal microcirculation.11
As a non-invasive imaging technique, optical coherence tomography (OCT) has been 
commonly used worldwide for clinical diagnosis of some ocular diseases. Moreover, OCT 
has also been explored in a research capacity in MS. Using commercial OCT, it has been 
demonstrated that retinal structure defects occur in MS patients, such as thinning of the 
retinal nerve fibre layer (RNFL) and the combined retinal ganglion cell and inner plexiform 
layers.12 These changes are due to retrograde axonal degeneration of the optic nerve axons 
after clinically apparent and subclinical ON, and possibly due to primary neurodegenerative 
pathology. OCT technology can provide retinal structural information and also blood 
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perfusion information in some retinal diseases. Doppler OCT has been able to obtain precise 
measurement of total retinal blood flow calculated from the Doppler frequency shift of 
backscattered light. While appropriate for large vessels around ONH, Doppler OCT is not 
sensitive enough to accurately measure the low velocities of small vessels.13
Recently, we developed a method of measuring local circulation using high-speed OCT to 
perform quantitative angiography. Using the split-spectrum amplitude-decorrelation 
angiography (SSADA) algorithm, ONH perfusion can be quantified.14 The purpose of this 
study was to measure the microcirculation in the ONH and parafoveal retinal regions of MS 
eyes with and without a history of ON compared with healthy control (HC) eyes, and to 
investigate the retinal haemodynamic changes in MS. To the best of our knowledge, this is 
the first study using OCT angiography in MS.
METHODS
Study population
This study was performed at the Casey Eye Institute at the Oregon Health & Science 
University (OHSU, Portland, Oregon, USA). The research protocols were approved by the 
institutional review boards and carried out in accordance with the tenets of the Declaration 
of Helsinki. Written informed consent was obtained from each subject after explanation of 
the nature of this study.
The HC subjects were part of the Advanced Imaging for Glaucoma Study (AIGS). Their 
inclusion criteria were a normal Humphrey Swedish Interactive Threshold Algorithm 
(SITA) 24-2 standard visual field within 95% limits of the normal reference, intraocular 
pressures (IOP) of less than 21 mm Hg in both eyes, glaucoma hemifield test within 97% 
limits, normal appearing ONH and RNFL, central corneal thickness of more than 500 μm, an 
open anterior chamber angle as observed by gonioscopy, and no history of ocular or 
systemic corticosteroid use (http://www.AIGStudy.net).
All patients with MS were referred by the MS Center of Oregon at OHSU. All patients with 
MS fulfilled the 2005 panel MS criteria. Disability was assessed by the self-reported 
Expanded Disability Status Scale score (EDSS) and the physician-rated European Database 
for Multiple Sclerosis (EDMUS) Grading Gcale. MS inclusion criteria were physician-
confirmed diagnosis of MS (any subtype acceptable, eg, relapsing-remitting, secondary 
progressive, primary progressive), age 18–70 years old, able to comply with study 
procedures (transfer to a chair), and corrected visual acuity of at least 20/200 in either eye. 
Exclusion criteria were intravenous or oral steroids in the prior 30 days, MS exacerbation in 
the prior 60 days, evidence on ophthalmological exam within the last year of other ocular 
diseases or pathology that would confound the assessment (eg, glaucoma, diabetic or 
hypertensive retinal disease, amblyopia, etc.), previous intraocular surgery except for 
uncomplicated cataract extraction with posterior chamber intraocular lens implantation, 
inability to cooperate with OCT scanning, or refractive error greater than +3 or −7 dioptres. 
A medical history of ON prior to enrolment was determined by self-report and physician 
report, and confirmed by record review. Patients with an ongoing attack of ON in either eye 
were excluded from this study.
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MS eyes were categorised into two groups. Patients without ON were placed in the MS−ON 
group, and those with ON were placed in the MS+ON group.
OCT data acquisition and processing
The prototype high-speed swept-source OCT system operated at an axial scan speed of 100 
KHz using 1050 nm wavelength laser (Axsun Technologies, Billerica, Massachusetts, USA) 
with a tuning range of 100 nm. The image resolution was 5.3 μm axially and 18 μm laterally.
A 3×3×3 mm three-dimensional (3D) volumetric scan centred on the ONH/fovea was 
captured for blood flow measurements. In horizontal priority (x-fast) scans, the beam is 
moved horizontally (x dimension) to form a 3 mm-long line scan for cross-sectional imaging 
(B-scan). Each B-scan contains 200 spots (axial scans). At each vertical (y) position, eight 
consecutive B-scans were captured in order to detect motion. The B-scan is then shifted 
slightly to a new position along the slow (vertical) axis. A total of 200 slow-axis locations 
were sampled to form a 3D data cube. A total of 1600 B-scans were acquired in 
approximately 3.5 s. In vertical priority (y-fast) scans, the role of the x and y axes were 
reversed. Four 3D scans, comprising two horizontal priority (x-fast) scans and two vertical 
priority (y-fast) scans were obtained in one session.
The SSADA algorithm was used to distinguish flowing blood from static tissue.14 As seen 
in real-time OCT reflectance images, the amplitude of signal backscattered from non-static 
tissue varies rapidly over time.14 By calculating the decorrelation of signal amplitude from 
consecutive B-scans, a contrast between static and moving tissue is created. Blood vessels 
are characterised by motion-induced decorrelation in the lumen. The faster blood particles 
move across the laser beam, the higher is the decorrelation of the detected signals within a 
velocity range set by the scan parameters. Thus, decorrelation is approximately linear to 
flow velocity, that is, the distance travelled by red blood cells flowing across the light beam 
per unit time.15 However, beyond a saturation velocity that is defined by the time interval 
between consecutive OCT B-scans, the decorrelation increases more slowly with velocity 
and eventually reaches an upper boundary.15
Eye motion causes two types of artefacts in SSADA. First, motion between consecutive B-
scans at the same nominal position causes decorrelation that can appear as flow. Second, 
motion between B-scan positions distorts the transverse position of scans along the slow 
scan axis. To correct the first type of motion error, B-scans with very large (saccadic) bulk 
motion artefacts were removed. Furthermore, decorrelation due to bulk tissue motion was 
calculated by histogram analysis and subtracted from each cross-sectional SSADA frame.14 
To correct the second type of motion artefact, we used an image registration algorithm that 
registered four orthogonal raster-scanned volumes.16 Motion correction was first performed 
on the structural OCT data. The motion correction algorithm generated 3D displacement 
fields that map A-scans from the input volumes into a common motion-corrected space. The 
same displacement fields were applied to the decorrelation (flow) data to produce motion-
corrected flow data volumes. Flow data from four input volumes were weighted and merged, 
improving the signal-to-noise ratio in the flow signal, and reducing the flow measurement 
variation due to local flow changes caused by the cardiac cycle.
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To measure ONH perfusion, cross-sectional registered intensity images and flow images 
were summarised and viewed as an en face maximum projection. The elliptical boundary 
was manually delineated on the en face intensity images and transferred to the OCT 
angiogram for disc region segmentation. The ONH flow index (FI) was defined as the 
average flow signal (decorrelation value) within the whole ONH. To measure parafoveal 
retinal perfusion, retinal circulation was segmented along the boundary set at retina pigment 
epithelium in intensity images and separately projected into en face view. The fovea was 
manually centred at the avascular zone on the OCT angiogram. The parafoveal retinal FI 
was defined as the average flow signal within the annular zone of 0.6 to 2.6 mm diameter 
around the foveal centre (figure 1).14 The central 0.6 mm diameter area (foveal avascular 
zone) of normal controls was used to determine the noise floor. The decorrelation values 
above noise floor are flow signals from either large vessels (bright signals in figure 1) or 
capillaries (weak signals in figure 1), and used for the calculation of FI. FI is a 
dimensionless parameter between 0 and 1. Due to the non-linear relationship between 
decorrelation and flow velocity, the FI mainly measured the area (or calibre) of large vessels 
and the area (or vessel density) and velocity of capillaries.
Repeatability and reproducibility
Intravisit repeatability of the ONH and parafoveal FIs were calculated from three patients 
with HC with three sets of scans within a single visit by a single operator. Intervisit 
reproducibility of the ONH and parafoveal FIs was calculated from three patients with HC 
with three sets of scans obtained on three separate visits by the same operator.
Statistical analysis
Statistical analyses were performed with commercial software (SPSS V.13.0; SPSS, 
Chicago, Illinois, USA). The coefficient of variation (CV) was calculated to assess 
repeatability and reproducibility of the ONH and parafoveal FIs. Best corrected visual acuity 
(BCVA) was converted to a log of the minimum angle of resolution (logMAR) for statistical 
analysis, and two-tailed independent sample t tests were used to compare the mean logMAR 
BCVA values of each group. The Mann–Whitney U test was used to analyse the FI 
differences between each group. The χ2 test was performed to compare the percentile 
differences between groups. All the tests had a significance level of 5%.
RESULTS
A total of 36 patients with MS (70 eyes) and 27 patients with HC (one eye for each patient, 
27 eyes) were studied. For all patients, 24 eyes were excluded due to low signal strength (8 
eyes), failed 3D registration (6 eyes), poor scan centration (10 eyes) for either ONH or 
macula scans. Therefore, 35 patients with MS (52 eyes) and 21 patients with HC (21 eyes) 
were included in the final analysis (table 1). Patients with HC tended to be older than the 
patients with MS, but were well matched for IOP and visual acuity. Patients with MS −ON 
were slightly older with shorter disease duration than the patients with MS +ON. The two 
MS subgroups were well matched for disability (EDSS, EDMUS), visual acuity and IOP.
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Typical examples of ONH angiograms and macular retinal angiograms for HC and MS 
groups showed notable attenuation of ONH circulation in the MS+ON group (figure 1). The 
mean ONH FI in MS+ON group was significantly lower than the HC and MS−ON groups 
(p=0.004 for both), while there was no significant difference between the HC and MS−ON 
groups (p=0.924; figure 2). There were no significant differences in the mean parafoveal FIs 
among the three groups.
Using the normative distribution of FI in the HC group, FI values were classified as within 
normal limits, borderline, or abnormal (table 2). Abnormal values were defined as those 
more than −2.33 SDs below the mean (1st percentile cutoff for normal distribution). 
Borderline values were defined as those between 1.65 and 2.33 SD below the mean 
(between 1st and 5th percentile cutoffs). A significantly higher percentage of MS+ON eyes 
had an abnormally low ONH FI compared to HC eyes (43% vs 5%, p=0.01). Twenty-one 
per cent of MS−ON eyes also had an abnormally reduced ONH FI (p=0.198). In the MS
−ON group, the parafoveal FI was within the normal range for all eyes except one, thus, 
there were no significant differences among the three groups (table 2).
Three HC eyes were scanned to assess intravisit repeatability and intervisit reproducibility 
of repeated measurements by pooled CV. The repeatability and reproducibility were 1.03% 
and 4.53% for ONH FI, and 1.65% and 3.55% for parafoveal FI, respectively. The 
intersubject variability of ONH and parafoveal FIs, which was evaluated by the CV in 21 
HC eyes, was 6.3% and 7.7%, respectively.
DISCUSSION
As interest in the contribution of vascular disease to MS and ON pathophysiology is 
growing, we used OCT angiography to examine the ONH and retinal microcirculation 
changes in MS eyes with or without ON history. Our results showed that the ONH FI of MS 
+ON eyes was significantly lower than the values of the HC group and the MS −ON group. 
We also found that the MS +ON eyes had a significantly higher percentage of abnormally 
low ONH FI than the HC eyes. Moreover, ~21% of MS −ON eyes, despite a normal visual 
acuity, showed abnormal low ONH FI.
There are several possible reasons for the decreased blood perfusion in ONH of MS patients. 
First, MS damages and reduces the number of nerve fibres in the optic nerve, ONH and 
RNFL which, in turn, reduces metabolic activities. The reduced metabolic load lowers blood 
flow via autoregulatory mechanisms. MS is associated with a loss of peripapillary RNFL, a 
structural marker of axonal degeneration, using structural OCT system.17 Fisher et al12 
found that MS +ON eyes demonstrated the greatest reduction in RNFL thickness, while MS 
−ON eyes had a lesser degree of RNFL reduction, when compared to disease-free control 
eyes. Our finding of the greatest loss of ONH FI in MS +ON eyes is consistent with this 
work. Second, there could be primary vascular dysfunctions, such as the endothelial 
abnormalities that have been noted in the brains of patients with MS.3–5
No significant differences in parafoveal FI were found among the three groups in this study. 
MS and ON are associated with macular ganglion cell loss, therefore, this result was 
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unexpected, especially in contrast with the reduction in ONH FI. A possible explanation is 
that MS and ON only affect the innermost retinal layers, therefore, the middle retinal layers 
still had sufficient functionality to maintain autoregulation of macular blood flow in the 
normal range. Another explanation is that MS and ON often cause only minimal damage to 
foveal function, as evidenced by only 12% (6 eyes) of MS eyes having reduction in BCVA 
of two or more lines. Our results suggest that parafoveal FI is a relatively insensitive way to 
detect the damage caused by MS. Yet another possible explanation is that MS produces 
primary vascular dysfunctions in the optic nerve, which does affect the retina.
There are several other techniques that can detect decreased ONH perfusion in MS and ON 
patients. Using FA, Duker et al18 showed that ON is associated with delayed venous filling 
accompanied by venous dilation and tortuosity. Using colour Doppler ultrasonography, 
Modrzejewska et al19 found that the reduction of blood flow parameters in the central retinal 
artery and short posterior ciliary artery occurred in the ON-affected eyes and the fellow 
eyes. Using CDI, Akarsu et al20 also demonstrated that MS +ON was associated with 
impaired retrobulbar haemodynamics. Conversely, Hradilek et al21, also using CDI, failed to 
find an orbital haemodynamic difference between eyes with chronic ON and the control 
group.
Compared with the techniques mentioned above, OCT angiography is more repeatable, more 
reproducible, and less variable. It has been reported that 24 h reproducibility of LDF and 
CDI were between 1.6% and 18.5% CV.22 For LSFG, the inter-session reproducibilities of 
retinal veins and arteries were 8.4 ±5.6% and 10.9±9.9% CV.23 Using modified laser 
speckle technology, the ONH blood velocity reproducibility with 1 min and 24 h intervals 
were 11.7% and 13%, respectively.24 Likewise, intersubject variability of HC patients were 
much higher in MRI (~33%), LDF (17~21%), and LSFG (~38.4%) compared to OCT 
angiography (~7%).102425 The higher repeatability and reproducibility suggests that OCT 
angiography may be more suitable than other imaging techniques for detecting and 
monitoring of abnormal ONH and parafoveal perfusion changes.
OCT angiography requires high scan speed. Therefore, a prototype OCT system with higher 
speed (100 kHz) than commercially available OCT instruments was used in this study. The 
next generation of commercial OCT systems with 70 kHz speed are fast enough for OCT 
angiography. Therefore, this new method of assessing ONH circulation could be easily 
accessible in the near future. Although MRI is still needed to detect the characteristic white 
matter lesions in the brain and establish MS diagnosis, OCT evaluation of optic nerve 
structure and perfusion could be a relatively low-cost method for quantifying the damage 
caused by MS.
The current study had some limitations. The study sample size was relatively small. Some 
(~15%) eyes were excluded due to weak signal (media opacity, dry eye, poor beam focusing 
or position), failed 3D registration (excessive eye motion or blink), or poor scan centration. 
Therefore, the technique requires careful operator technique and some patient selection. 
Further studies with histopathological or other correlations are necessary to help understand 
the mechanisms of the changes of ONH microcirculation. However, our results are 
promising.
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In conclusion, OCT angiography with the SSADA algorithm is highly repeatable and 
reproducible for FI measurement of the ONH and parafoveal regions. It was able to detect 
reduction of ONH perfusion in a significant portion of MS patients with or without a history 
of ON. Additional studies will explore further the structure-function-perfusion relationships 
in MS to help determine if perfusion can provide early insights into MS pathology and 
progression. This new technology may be useful in the detection and monitoring of optic 
nerve damage caused by MS and ON.
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Figure 1. 
En face optical coherence tomography angiograms of the optic nerve head (ONH) and 
macula in representative healthy control group (HC; A1, A2), multiple sclerosis without 
optic neuritis group (MS−ON; B1, B2), and multiple sclerosis with optic neuritis group (MS
+ON; C1, C2). In the ONH angiograms (A1–C1), the flow index (FI) was averaged over the 
whole ONH (solid red circles). In comparison with the HC and MSON examples, the whole 
ONH microvascular network in MS+ON eye showed attenuation. In the macula retinal 
angiograms (A2–C2), the parafoveal FI was averaged over an annulus between diameters 
0.6 mm (red circle) and 2.6 mm (yellow dotted circle). The parafoveal microvascular 
network in these examples showed no clear differences.
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Figure 2. 
Box plots showing the optic nerve head (ONH) flow index (FI) (A) and the parafoveal FI 
(B) in healthy control (HC), MS −ON, and MS +ON groups. The median (dark bold line), 
IQR (box) and the whole range of values (whiskers) are shown. Mann–Whitney U tests 
showed significant reduction in the ONH FI of the MS +ON group compared to HC and MS 
−ON groups (p values shown in panel A). MS, multiple sclerosis, NS, non-significant; n, 
number of eyes.
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Table 1
Characteristics of the study groups
Group (patients/eyes)
HC (21/21) MS −ON (25/38) MS +ON (10/14)
Age (yrs) 50±9.6 47±12.7 40±8.9
High-contrast LogMAR BCVA 0.01±0.1 0.04±0.1 0.01±0.1
Low-contrast LogMAR BCVA none 0.65±0.2 0.72±0.2
EDSS n/a 3.8±1.7 3.2±1.9
EDMUS n/a 2.5±2.0 3.0±2.0
IOP (mm Hg) 15±2.3 15±3.1 14±2.2
MS duration (yrs) n/a 12±8.4 17±10.4
BCVA, best corrected visual acuity; EDMUS, European Database for Multiple Sclerosis Grading Scale; EDSS, Expanded Disability Status Scale; 
HC, healthy control; IOP, intraocular pressure; MAR, minimum angle of resolution; MS, multiple sclerosis; MS+ON, MS with history of ON; MS
−ON, MS without history of ON; n/a, not applicable; ON, optic neuritis.
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